Drug Trial Radar · NCT07668466
Intradiscal rhGDF-6 for the Treatment of Lumbar Disc Degeneration
Last checked: Nov 20, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jul 4, 2026
Primary completion
Aug 31, 2028
Study completion Dec 1, 2030
Sponsor
- Lead sponsor
- Cartago Biotech Pty LtdIndustry
- Sponsor type
- Industry
- First posted
- Jun 25, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to find out if a new medicine can help people who have long-lasting back pain caused by damaged spinal discs. The study will also check if the medicine is safe to use. The main questions this study aims to answer are: Is the medicine safe, and what amount works best? Can it reduce long-term back pain? Researchers will test a medicine called CBT005, which contains a healing protein, by injecting it into the spinal discs. They will watch closely to see how people respond to the treatment. Participants will: Receive one study injection into the spinal disc Visit the clinic in person during the first 12 months for checkups Receive phone calls at 24 and 36 months to see how they are doing Still be able to get other pain treatments in the future, including surgery, if needed
Conditions
- Disc Degenerative Disease
- Back Pain
Interventions
High DoseBiological
High Dose: 4 mg dose of Growth differentiation factor 6
Low DoseBiological
Low dose: 2mg dose of Growth differentiation factor 6
Primary outcomes
What the sponsor says the trial is designed to measure.
- Neurological StatusTime frame: From enrollment through to 12 months
- Oswestry Disability Index (ODI)Time frame: Enrollment through to 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Spine & Scoliosis Service
Kogarah, New South Wales, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.